ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

OXB Oxford Biomedica Plc

328.00
28.00 (9.33%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Oxford Biomedica Plc LSE:OXB London Ordinary Share GB00BDFBVT43 ORD 50P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  28.00 9.33% 328.00 325.50 330.00 350.00 303.00 304.00 1,285,192 16:35:22
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Medicinal Chems,botanicl Pds 139.99M -45.16M -0.4676 -6.95 313.89M
Oxford Biomedica Plc is listed in the Medicinal Chems,botanicl Pds sector of the London Stock Exchange with ticker OXB. The last closing price for Oxford Biomedica was 300p. Over the last year, Oxford Biomedica shares have traded in a share price range of 164.40p to 473.00p.

Oxford Biomedica currently has 96,580,639 shares in issue. The market capitalisation of Oxford Biomedica is £313.89 million. Oxford Biomedica has a price to earnings ratio (PE ratio) of -6.95.

Oxford Biomedica Share Discussion Threads

Showing 26751 to 26773 of 26775 messages
Chat Pages: 1071  1070  1069  1068  1067  1066  1065  1064  1063  1062  1061  1060  Older
DateSubjectAuthorDiscuss
04/5/2024
10:10
Happy international StarWars day everybody. May the 4th be with you and all that.

OXB try to avoid 3rd parties for recruitment. You can see what they are looking for at any particular time via that link on their website



11 at the moment.

Kingzog wins the prize for getting post 7777.

harry s truman
04/5/2024
07:50
Has anyone here still been topping up since we headed above 3 quid...someone must have been buying :)
takeiteasy
04/5/2024
07:31
''The scope of recruitment will include from junior to director level roles.''
mirabeau
04/5/2024
07:29
OXB embarking on a hiring spree for numerous roles, from 'toilet cleaner' to Director. Expansion no doubt in expectation of volume led work as per ''Build Talent Pools for specific high volume roles'' :


Talent Acquisition (Recruitment) Specialist

Oxford BioMedica (UK) Limited
OXFORD
Salary - To define
Start date - 3 May 2024
Closing date - 31 May 2024

Job description:

We are currently recruiting for a Talent Acquisition Specialist to join the Human Resources team, initially for a 12 month fixed term contract. The purpose of this role is to partner closely with assigned senior level stakeholders, acting as an advisor and taking ownership for the end-to-end recruitment lifecycle, from recruitment briefing meeting, advertising, sourcing, arranging interviews and making job offers, negotiating and agreeing final packages. The scope of recruitment will include from junior to director level roles.



Your responsibilities in this role would be:



For assigned roles, you will manage the end-to-end recruitment process. This includes:

Conduct a Recruitment Briefing Meeting with the Hiring Manager to ensure an understanding of the requirements of the vacancy and the interview process, providing guidance on the current candidate market place

Source

Develop job adverts to post and advertise vacancies
Search and ‘headhunt’ candidates directly for niche roles
Build Talent Pools for specific high volume roles
Promote the Employee Referral program and encourage internal development and movement
Advertise on LinkedIn and JobBoards, promoting the Employee Value Proposition

cont......

mirabeau
03/5/2024
14:34
On for one million shares traded on a Friday before a May Bank holiday with a 10% rising share price. Not bad?
gareth jones
03/5/2024
13:42
US Payrolls missed, rate cut probability increased, indices rally.
mirabeau
03/5/2024
13:28
No doubt about it. America are buying in having been left out earlier in the day.
dominiccummings
03/5/2024
12:49
I must say Harry that it's worth holding OXB just to get an education on what's going on in the pharmacy sector. Keep up the good work!
ygor705
03/5/2024
12:41
We now have a high quality problem on our hands. I liken the recent movement in the share price to starting a very big fire at a tyre factory viz it is very visible and will attract attention from miles around. This could push the spike here quite high but it will then be interesting to see if a sudden fall sucks in more buyers. I seem to remember comment that shares were being issued at c.£4 at the time of the French acquisition: perhaps that a good starting point for genuine current share price value.
ygor705
03/5/2024
12:32
I have no idea what is going on either, but it does remind me of a time when buying a few SCI at 270p, seeing them go to 330p. It was an illiquid stock and when a forced seller appeared, the MM's walked the price down to <50p. Once the seller dumped the final tranche, the price moved upwards rapidly almost hitting 700p.
strapittoyourankle
03/5/2024
12:28
i would like to thank Harry for his posts.i am now back in profit having been looking at a big loss. Without those well informed posts i probably would have lost the faith.
edwardt
03/5/2024
11:56
Is there more to this than a lovely set of results - if this was always worth 4-5 on worst case Harry, why did it ever get so low...I find this whole episode very odd. Perhaps it is simply the RR type scenario when the market gets too down on a great business?

back into an auction - unbelievable :)

takeiteasy
03/5/2024
11:54
Wowza.... looking great.:)
kumala
03/5/2024
11:27
There has being a lot of pain watching the decline of OXB price over the last while.

My smile is widening by the minute... think we are all entitled to some sunshine .

Enjoy

connello
03/5/2024
11:18
After the half year results, IM bought aggressively as part of their stated aim to get to 10% and that took the price rapidly to £3. As we know, they may not actually need to buy any more in the market to get to 10% once the EUR20m shares are issued later in the year.

It could be, if they are not currently inside on anything, that they have taken the view to aim to go beyond 10%? They were very clear before on their aims, but I don't think they'd need to announce any change to that in advance?

cousinit
03/5/2024
11:16
Well done all 🍒🍒&#127826;
linton5
03/5/2024
11:06
I'm intrigued to know what's driving this
mirabeau
03/5/2024
10:50
AlliancePharma [APH] has an impressive record of long-term growth & creating sustainable value for our shareholders & stakeholders-DIVIDEND +5% -PORTFOLIO BROADENED THROUGH ACQUISITION
blackhorse23
03/5/2024
10:36
I think we're all assuming OXB does the one step back at some point, but so far on the Friday of a bank holiday weekend when I'd normally expect a slow day - no sign of it.

FTSE quarterly review is the end of this month. 580p+ would be back in the FT250 and all sins forgiven. I honestly wasn't expecting that so soon after the results, but similarly if it did happen by some circumstance of events (like whatever is causing this movement and / or the insiders not buying) then it wouldn't surprise me either.

harry s truman
03/5/2024
10:27
I bet that DB note's been circulating for a few weeks, no wonder the price took off mid-April
mirabeau
03/5/2024
10:24
They want their clients to get in first :)
takeiteasy
03/5/2024
09:46
SMALL CAP

----------

Deutsche Bank initiates Oxford BioMedica with ’hold’ - target 250 pence

----------

Well that's helpful. Best not mention the war eh?

harry s truman
03/5/2024
09:42
120k print
mirabeau
Chat Pages: 1071  1070  1069  1068  1067  1066  1065  1064  1063  1062  1061  1060  Older

Your Recent History

Delayed Upgrade Clock